ゲノミクスにおけるAIの世界市場レポート 2024年

ゲノミクスにおけるAIの市場規模は近年急激に拡大しています。2023年の7億5,000万米ドルから2024年には10億8,000万米ドルへと、CAGR43.9％で成長します。ゲノミクスにおけるAI分野の実績期間に観察された成長は、いくつかの要因に起因しています。ゲノムシーケンス技術の進歩、大規模なゲノムデータセットの取り扱いと解析に関する課題、個別化医療に対する需要の高まり、ゲノミクスによる疾患の理解と診断への注目の高まり、創薬・開発プロセスにおけるAIの応用などです。これらの要因が、ゲノム研究におけるAIツールの開発と採用に寄与しています。

2023年のゲノミクスにおけるAI市場では北米が最大地域でした。アジア太平洋は、予測期間中、ゲノム研究におけるAI市場レポートにおいて最も急成長する地域となる見込みです。ゲノミクスにおけるAI市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 ゲノミクスにおけるAIの市場の特徴

第3章 ゲノミクスにおけるAIの市場の動向と戦略

第4章 ゲノミクスにおけるAIの市場-マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 ゲノミクスにおけるAIの市場規模と成長

• ゲノミクスにおけるAIの市場の促進要因と制約要因
  • 市場の促進要因
  • 市場の抑制要因
• ゲノミクスにおけるAIの市場規模の実績と成長、2018-2023
• ゲノミクスにおけるAIの市場規模と成長予測、2023-2028、2033年

第6章 ゲノミクスにおけるAIの市場セグメンテーションにおけるAI

• ゲノミクスにおけるAIの世界市場、構成別セグメンテーション、実績および予測、2018-2023、2023-2028、2033年
  • ハードウェア
  • ソフトウェア
  • サービス
• ゲノミクスにおけるAIの世界市場、技術別セグメンテーション、実績および予測、2018-2023、2023-2028、2033年
  • 機械学習
  • コンピュータビジョン
• ゲノミクスにおけるAIの世界市場、機能別セグメンテーション、実績および予測、2018-2023、2023-2028、2033年
  • ゲノム配列決定
  • 遺伝子編集
  • その他の機能
• ゲノミクスにおけるAIの世界市場、アプリケーション別セグメンテーション、実績および予測、2018-2023、2023-2028、2033年
  • 創薬と開発
  • 精密医療
  • 診断
  • その他の用途
• ゲノミクスにおけるAIの世界市場、エンドユース別のセグメンテーション、実績および予測、2018-2018-2023、2023-2028、2033年
  • 製薬会社およびバイオテクノロジー企業
  • ヘルスケア提供者
  • 研究センター
  • その他のエンドユーザー

第7章 ゲノミクスにおけるAIの市場の地域および国分析

• ゲノミクスにおけるAIの世界市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• ゲノミクスにおけるAIの世界市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 ゲノミクスにおけるAIの市場の競合情勢と企業プロファイル

• ゲノミクスにおけるAIの市場の競合情勢におけるAI
• ゲノミクスにおけるAIの市場におけるAI企業プロファイル
  • International Business Machines Corporation
  • Microsoft Corp.
  • NVIDIA Corporation
  • Deep Genomics Inc.
  • BenevolentAI Ltd.

第31章 ゲノミクスにおけるAIの世界市場の競合ベンチマーキング

第32章 ゲノミクスにおけるAIの世界市場の競争ダッシュボード

第33章 ゲノミクスにおけるAIの市場の主要な合併と買収

第34章 ゲノミクスにおけるAIの市場の将来展望と可能性分析

第35章 付録

“AI In Genomics Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on air in genomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for air in genomics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The air in genomics market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Component: Hardware; Software; Services
• 2) By Technology: Machine Learning; Computer Vision
• 3) By Functionality: Genome Sequencing; Gene Editing; Other Functionalities
• 4) By Application: Drug Discovery And Development; Precision Medicine; Diagnostics; Other Applications
• 5) By End-use: Pharmaceutical and Biotech Companies; Healthcare Providers; Research Centers; Other End-Users
• Companies Mentioned: International Business Machines Corporation; Microsoft Corp.; NVIDIA Corporation; Deep Genomics Inc.; BenevolentAI Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

AI in genomics refers to a collection of computer tools utilized by genomics researchers to handle and decipher critical information embedded in large datasets generated from DNA sequencing and other biological processes. These algorithms are designed to identify patterns and abnormalities within genomic data, aiding researchers in understanding the complexities of the human genome.

The main components involved in AI in genomics include hardware, software, and services, with machine learning and computer vision as the key technologies. Hardware encompasses both external and internal components and equipment that enable users to perform various operations such as input, output, storage, communication, and processing. The main functionalities of AI in genomics include genome sequencing, gene editing, and others, and these technologies find applications in diverse areas, including drug discovery and development, precision medicine, diagnostics, and more. The major end-users of AI in genomics include pharmaceutical and biotech companies, healthcare providers, research centers, and other entities involved in genomics research.

The AI in genomics market research report is one of a series of new reports from The Business Research Company that provides AI in genomics market statistics, including AI in genomics industry global market size, regional shares, competitors with an AI in genomics market share, detailed AI in genomics market segments, market trends and opportunities, and any further data you may need to thrive in the AI in genomics industry. This AI in genomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ai in genomics market size has grown exponentially in recent years. It will grow from $0.75 billion in 2023 to $1.08 billion in 2024 at a compound annual growth rate (CAGR) of 43.9%. The growth observed during the historical period in the field of AI in genomics can be attributed to several factors. These include advancements in genomic sequencing technologies, challenges related to the handling and analysis of large genomic datasets, the increasing demand for personalized medicine, a growing focus on understanding and diagnosing diseases through genomics, and the application of AI in drug discovery and development processes. These factors collectively contributed to the development and adoption of AI tools in genomics research during that timeframe.

The ai in genomics market size is expected to see exponential growth in the next few years. It will grow to $4.58 billion in 2028 at a compound annual growth rate (CAGR) of 43.4%. The anticipated growth in the forecast period for AI in genomics can be attributed to various key factors. These include the expansion of genomic databases, advancements in genomic data security measures, AI-driven biomarker discovery for various applications, integration of genomic data with other 'omics' data types, and a focus on patient empowerment and education in genomics. Major trends expected in the forecast period include the use of AI in cancer genomics, AI-enhanced genomic imaging technologies, continued efforts in AI-driven biomarker discovery across different diseases, the integration of genomic data across healthcare systems, and the application of AI in functional genomics research. These trends collectively reflect the industry's response to technological advancements and the increasing integration of AI in various aspects of genomics research and healthcare.

The burgeoning adoption of AI is poised to drive the expansion of the AI in genomics market in the foreseeable future. Within the realm of computer science, AI, encompassing machine learning and deep learning, holds substantial promise for solving complex problems using vast datasets. In genomics, AI plays a pivotal role in identifying genetic disorders, primary cancer types, predicting disease progressions, pinpointing disease-causing genomic variations, and refining gene editing tools. The demand for AI in genomics is on the rise due to its myriad benefits. Notably, as of May 2022, an International Business Machines Corporation (IBM) report highlighted a significant surge in the global adoption rate of AI, escalating to 35%, a four percent increase from the preceding year. Furthermore, surveys of 7,502 decision-makers from various companies indicated a 13% rise in the expected utilization of AI in 2021 compared to 2020. Approximately 35% of organizations reported employing AI, while 42% contemplate its adoption, and two-thirds (66%) intend to deploy AI to meet their sustainability objectives. Hence, the escalating adoption of AI is a driving force behind the growth of the AI in genomics market.

The escalating adoption of personalized medicine methodologies is projected to propel the advancement of the AI in genomics market in the forthcoming years. Personalized medicine, also known as precision medicine, represents an innovative approach to healthcare that considers individual variations in genes, environments, and lifestyles when tailoring medical treatments. The integration of AI in genomics for personalized medicine not only augments the speed and precision of genetic analyses but also paves the way for customizing medical interventions for individual patients, thereby enhancing treatment outcomes and advancing precision medicine. For instance, in February 2023, the Personalized Medicine Coalition disclosed that personalized pharmaceuticals accounted for 34% of new medications approved by the US Food and Drug Administration in 2022, maintaining a consistent trend of comprising at least 25% of approvals over the past eight years. Therefore, the increasing utilization of personalized medicine strategies acts as a catalyst for the growth of the AI in genomics market.

Technological advancements constitute a significant and growing trend within the AI in genomics market. Prominent industry players are intensely focused on developing innovative technological solutions to bolster their market standing. For example, in March 2023, Genomic Vision, a France-based biotechnology firm specializing in diagnostic solutions for genetic diseases and cancers, unveiled FiberSmart, an AI-powered software designed for the visualization and high-resolution analysis of lengthy DNA fibers. This groundbreaking technology has the potential to revolutionize the diagnosis and treatment of genetic disorders by enhancing precision and efficacy in diagnosis and treatment. The software analyzes substantial volumes of data to unveil patterns and insights that would otherwise be beyond human capacity to discern independently.

Major players within the AI in genomics market are strategically pursuing partnerships to elevate patient care standards. Strategic partnerships involve companies leveraging each other's strengths and resources to attain mutual advantages and bolster success. For instance, in March 2022, the International Business Machines Corporation (IBM), a prominent US-based technology firm, unveiled a partnership with Genomics England. This collaboration entails IBM working with Genomics England across three key domains such as enhancing the clinical user interface, facilitating swift access to genetic data storage, integrating cloud capabilities within a hybrid cloud environment, and managing services. Genomics England, a UK-based government entity, oversees the 100,000 Genomes Project.

In May 2022, Sema4 Inc., a US-based AI-powered genomic and clinical data intelligence platform company, acquired GeneDx LLC for an approximate sum of $623 million. This strategic acquisition positions Sema4 as one of the foremost and most advanced providers of genomic testing in the United States. Moreover, it fortifies their health information repository, aiming to revolutionize patient care and augment advancements in therapeutic development. This acquisition further expedites Sema4's ability to deliver precision medicine while optimizing platform efficiency. GeneDx LLC, a US-based entity specializing in genetics and genomics, offers AI-enabled testing services to patients, aligning well with Sema4's objectives.

Major companies operating in the ai in genomics market report are International Business Machines Corporation, Microsoft Corp., NVIDIA Corporation, Deep Genomics Inc., BenevolentAI Ltd., Fabric Genomics Inc., Verge Genomic Inc., Freenome Holdings Inc., MolecularMatch Inc., SOPHiA GENETICS SA, Data4Cure Inc., PrecisionLife Ltd., Genoox Ltd., Lifebit Ltd., Empiric Logic Ltd., FDNA Inc., DNAnexus Inc., Engine Biosciences Pte Ltd., 4baseCare, Congenica Ltd., CytoReason Ltd., Emedgene Technologies LTD, Illumina Inc., Lifebit Biotech Ltd., Mendel.ai, Predictive Oncology Inc., Tempus Labs Inc., 10x Genomics Inc., Repositive Limited, Genedata AG, Global Gene Corp, Nference Inc., Bluebee Holding B.V., Genomenon Inc. .

North America was the largest region in the AI in genomics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the AI in the genomics market report during the forecast period. The regions covered in the ai in genomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the ai in genomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The AI in genomics market includes revenues earned by entities by providing services such as computer vision, time series analysis, automatic speech recognition, and natural language processing. The market value includes the value of related goods sold by the service provider or included within the service offering. The AI in genomics market also includes sales of neural network hardware, powered diagnostics and imaging machine which are used in providing AI in genomics services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. AI In Genomics Market Characteristics

3. AI In Genomics Market Trends And Strategies

4. AI In Genomics Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global AI In Genomics Market Size and Growth

• 5.1. Global AI In Genomics Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global AI In Genomics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global AI In Genomics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. AI In Genomics Market Segmentation

• 6.1. Global AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hardware
• Software
• Services
• 6.2. Global AI In Genomics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Machine Learning
• Computer Vision
• 6.3. Global AI In Genomics Market, Segmentation By Functionality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Genome Sequencing
• Gene Editing
• Other Functionalities
• 6.4. Global AI In Genomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Drug Discovery And Development
• Precision Medicine
• Diagnostics
• Other Applications
• 6.5. Global AI In Genomics Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Pharmaceutical and Biotech Companies
• Healthcare Providers
• Research Centers
• Other End-Users

7. AI In Genomics Market Regional And Country Analysis

• 7.1. Global AI In Genomics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global AI In Genomics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific AI In Genomics Market

• 8.1. Asia-Pacific AI In Genomics Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific AI In Genomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific AI In Genomics Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China AI In Genomics Market

• 9.1. China AI In Genomics Market Overview
• 9.2. China AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China AI In Genomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China AI In Genomics Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India AI In Genomics Market

• 10.1. India AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India AI In Genomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India AI In Genomics Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan AI In Genomics Market

• 11.1. Japan AI In Genomics Market Overview
• 11.2. Japan AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan AI In Genomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan AI In Genomics Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia AI In Genomics Market

• 12.1. Australia AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia AI In Genomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia AI In Genomics Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia AI In Genomics Market

• 13.1. Indonesia AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia AI In Genomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia AI In Genomics Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea AI In Genomics Market

• 14.1. South Korea AI In Genomics Market Overview
• 14.2. South Korea AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea AI In Genomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea AI In Genomics Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe AI In Genomics Market

• 15.1. Western Europe AI In Genomics Market Overview
• 15.2. Western Europe AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe AI In Genomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe AI In Genomics Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK AI In Genomics Market

• 16.1. UK AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK AI In Genomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK AI In Genomics Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany AI In Genomics Market

• 17.1. Germany AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany AI In Genomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany AI In Genomics Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France AI In Genomics Market

• 18.1. France AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France AI In Genomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France AI In Genomics Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy AI In Genomics Market

• 19.1. Italy AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy AI In Genomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy AI In Genomics Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain AI In Genomics Market

• 20.1. Spain AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain AI In Genomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain AI In Genomics Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe AI In Genomics Market

• 21.1. Eastern Europe AI In Genomics Market Overview
• 21.2. Eastern Europe AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe AI In Genomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe AI In Genomics Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia AI In Genomics Market

• 22.1. Russia AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia AI In Genomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia AI In Genomics Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America AI In Genomics Market

• 23.1. North America AI In Genomics Market Overview
• 23.2. North America AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America AI In Genomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America AI In Genomics Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA AI In Genomics Market

• 24.1. USA AI In Genomics Market Overview
• 24.2. USA AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA AI In Genomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA AI In Genomics Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada AI In Genomics Market

• 25.1. Canada AI In Genomics Market Overview
• 25.2. Canada AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada AI In Genomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada AI In Genomics Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America AI In Genomics Market

• 26.1. South America AI In Genomics Market Overview
• 26.2. South America AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America AI In Genomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America AI In Genomics Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil AI In Genomics Market

• 27.1. Brazil AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil AI In Genomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil AI In Genomics Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East AI In Genomics Market

• 28.1. Middle East AI In Genomics Market Overview
• 28.2. Middle East AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East AI In Genomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East AI In Genomics Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa AI In Genomics Market

• 29.1. Africa AI In Genomics Market Overview
• 29.2. Africa AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa AI In Genomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa AI In Genomics Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. AI In Genomics Market Competitive Landscape And Company Profiles

• 30.1. AI In Genomics Market Competitive Landscape
• 30.2. AI In Genomics Market Company Profiles
  • 30.2.1. International Business Machines Corporation
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Microsoft Corp.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. NVIDIA Corporation
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Deep Genomics Inc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. BenevolentAI Ltd.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global AI In Genomics Market Competitive Benchmarking

32. Global AI In Genomics Market Competitive Dashboard

33. Key Mergers And Acquisitions In The AI In Genomics Market

34. AI In Genomics Market Future Outlook and Potential Analysis

• 34.1 AI In Genomics Market In 2028 - Countries Offering Most New Opportunities
• 34.2 AI In Genomics Market In 2028 - Segments Offering Most New Opportunities
• 34.3 AI In Genomics Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer